Summary
Miroslav Gasparek is a biotech founder and CEO combining eight years of interdisciplinary experience in bioengineering, machine learning and synthetic biology to commercialize mRNA manufacturing at Sensible Biotechnologies. He has raised over $13M from top-tier US and European investors and built operations spanning Boston, Oxford and Bratislava while forming strategic industry partnerships. A PhD candidate at Oxford with a background from Imperial College London, his research applies control theory and systems engineering to synthetic biology — an unusual quantitative lens for a biotech CEO. He advises national and international bodies on biosecurity, has held roles with the Slovak Ministry of Health and WHO-related work, and serves on the board of the Alliance for mRNA Medicines. Co-founder of Nucleate UK and recognized on Forbes 30 Under 30 Europe, he pairs technical depth with venture and policy experience to advance scalable, supply-chain-resilient mRNA therapeutics. Colleagues describe him as equally likely to dig into ML control models or lead investor conversations over coffee.
8 years of coding experience
5 years of employment as a software developer
Master of Engineering (MEng) Bioengineering and Biomedical Engineering, Master of Engineering (MEng) Bioengineering and Biomedical Engineering at Imperial College London
Doctor of Philosophy - PhD Engineering, Doctor of Philosophy - PhD Engineering at University of Oxford
St Edmund's College & Prep School, Ware
Y Combinator
Physics Mathematics Biology Chemistry Economics English Slovak Spanish, Physics Mathematics Biology Chemistry Economics English Slovak Spanish at Private Secondary Grammar School, Žilina
English, Slovak, Czech, Spanish, German